skip to main
|
skip to sidebar
InviGoBlog
Paid To Popup
Friday, May 29, 2009
Bio-Rad "GTCA," FTW
Hat tip to Bnet Pharma, where
Trista Morrison provides a great overview
of the battle of the lab equipment supplier viral videos. Happy Friday.
Email subscribers,
click here if you can't see the video
.
Newer Post
Older Post
Home
Blog Archive
►
2011
(371)
►
October
(27)
►
September
(27)
►
August
(23)
►
July
(37)
►
June
(30)
►
May
(31)
►
April
(46)
►
March
(55)
►
February
(49)
►
January
(46)
►
2010
(520)
►
December
(52)
►
November
(32)
►
October
(26)
►
September
(34)
►
August
(30)
►
July
(43)
►
June
(41)
►
May
(52)
►
April
(53)
►
March
(50)
►
February
(46)
►
January
(61)
▼
2009
(463)
►
December
(65)
►
November
(26)
►
October
(26)
►
September
(26)
►
August
(24)
►
July
(30)
►
June
(39)
▼
May
(53)
FDA and EMEA: Minding the Gap
DotW: The Jury Is Out
Big Pharma ISO Big Democrat: Who Will Pfizer Land?
Bio-Rad "GTCA," FTW
The Next "Non-Interference" Clause
Conspicuous Consumption: FDA Makes TB a Priority
Exelixis/Sanofi: The Price of Playing in PI3K
GSK and Pfizer's HIV Joint Venture: Why It’s a Pat...
While You Were Long Weekending
DotW: Damned If You Do, Damned If You Don't
Notes from BIO: Getting Comfortable with REMS
Notes from BIO: Toast of the Coast--Incubator vs. ...
Notes from BIO: Merck's Take on Biomarker-Based Dr...
Notes from BIO: Biotech's Voice in Health Care Reform
Notes from BIO: A "Fire Drill" on Flu
JNJ Likes it Some Cougar. Rwwwaaarrrr!
Notes from BIO: A Big Gap In Industry's Plan For C...
Notes from BIO: Positive Message from Anti-Infecti...
GSK’s Tempero: Pushing Entrepreneurialism to the L...
Notes from BIO: NCI's Bridge Over FDA Troubles
Notes from BIO: Vaccine Applications to FDA Booming
Notes From BIO: Josh Boger Goes Back to Merck
Notes from BIO: Swag Review
Notes from BIO: Meet Merck-Serono's Portfolio Guru
Notes from BIO: BIO, Meet Sanofi; Sanofi, Meet BIO
Notes From BIO: Treating the Government as a Partner
Notes from BIO: Adimab Pulls Back the Curtain
Notes From BIO: The Pathology of Personalized Medi...
Notes from BIO: Delicious Drug Delivery
Notes from BIO: Not Just Another Report
Notes from BIO: TOUCH for Diabetes
Notes from BIO: Hey, Where'd Everybody Go?
Notes from BIO: The Times, They Are a Changin'
Notes from BIO: Bayer Quiet on Onyx Accusation
While You Were Getting Rained Out in Atlanta
Lyndon Baines Obama?
DotW: Meeting of the Minds
FDA Gives Cimzia the Thumbs Up in RA—At Last
OJ and Cheerios for Breakfast
Has PE-Backed Pharma R&D Risk Hedging Fizzled?
CMS Administrator Search: Glenn Steele Out?
Obama’s Health Reform Meeting: The Message Is The ...
Vanda's Iloperidone: Not Something You See Every Day
While You Were Calling Your Mother
DotW: Stress Test
Ode to Tamiflu Tearing Up the Charts
Pfizer Adds More Transparency on Emerging Markets
WTF? Regulatory Victory for Vanda's Iloperidone af...
Novartis Puts Its Money Where Its Mouth is, Too
The IN VIVO Blog Podcast: PSO Panel on Health Care...
FDA's Swine Flu Czar
While You Were Running for the Roses
DotW: Freak Out!
►
April
(35)
►
March
(51)
►
February
(40)
►
January
(48)
►
2008
(482)
►
December
(42)
►
November
(28)
►
October
(36)
►
September
(35)
►
August
(26)
►
July
(52)
►
June
(40)
►
May
(35)
►
April
(44)
►
March
(41)
►
February
(52)
►
January
(51)
►
2007
(182)
►
December
(32)
►
November
(42)
►
October
(37)
►
September
(33)
►
August
(29)
►
July
(9)
Followers
Total Pageviews